Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis
Atherosclerosis
· Elsevier
Аннотация
Publication date: Available online 19 November 2026 Source: Atherosclerosis Author(s): Yali Zhang, Yinglei Li, Bingqian Xie, Shuchang Liu, Jingjing Yu, Xi Chen, Liang Bai, Enqi Liu, Xiaojing Shi
Читать у издателя →
Цитирование
Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis. // Atherosclerosis. – URL: https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all
Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis. Atherosclerosis. https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all
“Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis.” Atherosclerosis.
@article{article106788,
title = {Macrophage MED1 deficiency aggravates atherosclerotic plaque vulnerability by impairing AMPK-dependent efferocytosis},
journal = {Atherosclerosis},
url = {https://www.sciencedirect.com/science/article/pii/S0021915026013341?dgcid=rss_sd_all}
}